The first study (NCT01029366) included R/R B-ALL patients alongside patients with other CD19-positive malignancies and the second one (NCT02030847) only included adults with CD19+ R/R B-ALL (113, 114). The gene discussed is CD19; the disease is acute lymphoblastic leukemia.